The Role of MicroRNA in Migraine: A Systemic Literature Review

[1]  P. Pozo‐Rosich,et al.  A study of differential microRNA expression profile in migraine: the microMIG exploratory study , 2023, The Journal of Headache and Pain.

[2]  Daohong Chen,et al.  Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: A placebo-controlled clinical trial , 2023, Frontiers in Molecular Neuroscience.

[3]  S. Yaşin,et al.  The holistic approach to the CHRNA7 gene, hsa-miR-3158-5p, and 15q13.3 hotspot CNVs in migraineurs , 2023, Molecular pain.

[4]  A. Gąsecka,et al.  The Role of MicroRNAs in Myocarditis—What Can We Learn from Clinical Trials? , 2022, International journal of molecular sciences.

[5]  S. Cottone,et al.  Abstracts of the 52nd Annual Conference of the Italian Society of Neurology , 2022, Neurological Sciences.

[6]  K. Goljanek-Whysall,et al.  MicroRNAs as the Sentinels of Redox and Hypertrophic Signalling , 2022, International journal of molecular sciences.

[7]  C. Tassorelli,et al.  Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine , 2022, Cells.

[8]  P. Ferdinandy,et al.  Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress , 2022, The Journal of Headache and Pain.

[9]  I. Clark,et al.  MicroRNA-Based Diagnosis and Therapy , 2022, International journal of molecular sciences.

[10]  J. Błasiak,et al.  Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine , 2022, International journal of molecular sciences.

[11]  T. Steiner,et al.  The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates , 2022, The Journal of Headache and Pain.

[12]  M. Tomaniak,et al.  Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring , 2022, Journal of clinical medicine.

[13]  Lixue Chen,et al.  MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model , 2021, Journal of neuroinflammation.

[14]  A. Velly,et al.  The role of a potential biomarker in patients with migraine: review and new insights , 2021, Expert review of neurotherapeutics.

[15]  H. Diener,et al.  Diagnosis and management of migraine in ten steps , 2021, Nature Reviews Neurology.

[16]  G. Mohaddes,et al.  The role of miRNAs in the regulation of autophagy in autoimmune diseases. , 2021, Life sciences.

[17]  N. Tran,et al.  miRNA interplay: mechanisms and consequences in cancer , 2021, Disease models & mechanisms.

[18]  M. Taheri,et al.  A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine , 2021, Journal of Molecular Neuroscience.

[19]  Chih-Hung Chou,et al.  Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome , 2020, Annals of neurology.

[20]  Xue-Mei Zhang,et al.  miR‐34a‐5p up‐regulates the IL‐1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons , 2020, FEBS open bio.

[21]  C.,et al.  Abstracts of the 51st Annual Conference of the Italian Society of Neurology , 2020, Neurological Sciences.

[22]  R. De Icco,et al.  Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? , 2020, The Journal of Headache and Pain.

[23]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[24]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[25]  S. Bottiroli,et al.  Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study , 2020, Cephalalgia : an international journal of headache.

[26]  M. Demir,et al.  MicroRNA and Cardiovascular Diseases , 2020, Balkan medical journal.

[27]  Hiroshi I. Suzuki,et al.  Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis , 2019, International journal of molecular sciences.

[28]  M. Foti,et al.  Deciphering miRNAs’ Action through miRNA Editing , 2019, International journal of molecular sciences.

[29]  R. Scherer,et al.  How should systematic reviewers handle conference abstracts? A view from the trenches , 2019, Systematic Reviews.

[30]  P. Gazerani.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment , 2019, Molecular Diagnosis & Therapy.

[31]  E. Cione,et al.  Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study , 2019, Journal of clinical medicine.

[32]  J. Błasiak,et al.  Mitochondria in migraine pathophysiology – does epigenetics play a role? , 2019, Archives of medical science : AMS.

[33]  K. Saliminejad,et al.  An overview of microRNAs: Biology, functions, therapeutics, and analysis methods , 2018, Journal of cellular physiology.

[34]  MTIS 2018 Abstracts , 2018, Cephalalgia.

[35]  Yen-Feng Wang,et al.  Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study , 2018, Cephalalgia : an international journal of headache.

[36]  E. Cione,et al.  microRNAs to Monitor Pain-migraine and Drug Treatment. , 2017, MicroRNA.

[37]  F. Cipollone,et al.  microRNA profiling in atherosclerosis, diabetes, and migraine , 2017, Annals of medicine.

[38]  Andrew D. Rouillard,et al.  The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins , 2016, Database J. Biol. Databases Curation.

[39]  H. H. Andersen,et al.  Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods , 2016, Molecular Neurobiology.

[40]  V. Rani,et al.  Exploring miRNA based approaches in cancer diagnostics and therapeutics. , 2016, Critical reviews in oncology/hematology.

[41]  F. Cipollone,et al.  MicroRNA profiling in migraine without aura: Pilot study , 2015, Annals of medicine.

[42]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[43]  N. Greig,et al.  Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders. , 2015, CNS & neurological disorders drug targets.

[44]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[45]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[46]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[47]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[48]  S. Silberstein.  Migraine , 2004, The Lancet.

[49]  A. Pisani,et al.  33° National Congress of the Italian Society for the Study of Headaches Naples (Italy), June 14 – 16, 2019 , 2019, Neurological Sciences.

[50]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.